Literature DB >> 30193753

Treatment of adult Graves' disease.

Bernard Corvilain1, Antoine Hamy2, Laurent Brunaud3, Françoise Borson-Chazot4, Jacques Orgiazzi5, Leila Bensalem Hachmi6, Mourad Semrouni7, Patrice Rodien8, Charlotte Lussey-Lepoutre9.   

Abstract

Treatment strategy in Graves' disease firstly requires recovery of euthyroid status by antithyroid therapy. Treatment modalities, precautions, advantages and side-effects are to be discussed with the patient. No particular treatment modality has demonstrated superiority. Pregnancy or pregnancy project affects choice of treatment and monitoring. Graves' orbitopathy is liable to be aggravated by iodine-131 treatment and requires pre-treatment assessment. Iodine-131 treatment aims at achieving hypothyroidism. Thyroid surgery for Graves' disease should preferably be performed by an expert team. In case of recurrence of hyperthyroidism, the various treatment options should be discussed with the patient. Empiric treatment of thyroid dermopathy uses local corticosteroids in occlusive dressing.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Antithyroid drugs; Antithyroïdien; Chirurgie; Graves’ disease; Grossesse; Maladie de Basedow; Myxœdeme prétibial; Orbitopathie; Orbitopathy; Pregnancy; Radioiode; Radioiodine; Surgery; Thyroid dermopathy

Mesh:

Substances:

Year:  2018        PMID: 30193753     DOI: 10.1016/j.ando.2018.08.003

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  5 in total

1.  Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves' hyperthyroidism.

Authors:  Jelte van der Vaart; Lynn Bosmans; Stijn F Sijbesma; Kèvin Knoops; Willine J van de Wetering; Henny G Otten; Harry Begthel; Inne H M Borel Rinkes; Jeroen Korving; Eef G W M Lentjes; Carmen Lopez-Iglesias; Peter J Peters; Hanneke M van Santen; Menno R Vriens; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 11.205

2.  Graves' Disease in the Young: Could We Change the Weather?

Authors:  Patrice Rodien
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

3.  Serum Levels of CXCL-13, RBP-4, and IL-6, and Correlation Analysis of Patients with Graves' Disease.

Authors:  Yanqin Hu; Yue Sun; Yuxuan Huang; Qiuxia Liu; Fan Ren
Journal:  Emerg Med Int       Date:  2022-08-12       Impact factor: 1.621

4.  Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.

Authors:  Keiichi Torimoto; Yosuke Okada; Shingo Nakayamada; Satoshi Kubo; Akira Kurozumi; Manabu Narisawa; Yoshiya Tanaka
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

5.  [Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease].

Authors:  Ali Sellem; Wassim Elajmi; Rania Ben Mhamed; Nesrine Oueslati; Haroun Ouertani; Hatem Hammami
Journal:  Pan Afr Med J       Date:  2020-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.